Key baseline disease characteristics in nAMD are not linked to treatment interval extension of aflibercept 8 mg: A post -hoc 96-week PULSAR analysis Conferences
- Overview
- Research
- Additional Document Info
- View All
Overview
status
publication date
- June 2024
has subject area
- 06 Biological Sciences (FoR)
- 11 Medical and Health Sciences (FoR)
- Ophthalmology & Optometry (Science Metrix)